ArticleFrontiers in veterinary science2026
On-site and visual detection of genotype VII Newcastle disease virus based on RT-RPA and CRISPR/Cas13a.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Newcastle Disease Virus (NDV) is not only a significant and persistent threat to the healthy development of poultry industry, but also an important pathogen endangering food safety and harboring potential zoonotic risks. Methods: In this study, a rapid and highly sensitive diagnostic assay was established for genotype VII NDV by integrating reverse transcription recombinase polymerase amplification (RT-RPA) with the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas13a system, in combination with a lateral flow dipstick (LFD) for visual signal readout. Specific RT-RPA primers were designed based on the fusion (F) gene of genotype VII NDV, and CRISPR RNAs (crRNAs) were constructed to establish a simplified CRISPR/Cas13a-based diagnostic workflow targeting the fusion (F) gene of genotype VII NDV. Results: The optimized detection platform integrates RT-RPA amplification at 39 °C for 20 min and CRISPR/Cas13a-mediated cleavage at 37 °C for 20 min. The final results can be quantified by fluorescence signals or visualized via LFD band within 5 min, with the total detection procedure completed in less than 45 min. Performance evaluation demonstrated that this assay achieved a limit of detection (LOD) as low as 6 copies per microliter of input and high specificity, with no cross-reactivity against other common avian pathogens. Clinical validation of 154 samples showed 100% concordance between the RT-RPA-CRISPR/Cas13a-(LFD) assay and RT-PCR sequencing for genotype VII NDV detection. Discussion: This method requires no sophisticated instruments and enables simple operation. It provides a field-deployable tool for rapid on-site detection of genotype VII NDV, which is suitable for preliminary screening in primary laboratories, and holds promising application potential for the early surveillance and food safety monitoring of virulent NDV strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.